Kentaro Suzuki serves as Executive at Nautilus Biotechnology, Inc., where they oversee executive responsibilities. Since joining the company, Kentaro Suzuki has executed 1 insider transactions totaling $6.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 6, 2025 involved purchasing 4,000 shares valued at $6.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 6, 2025 | NAUT | $6.0K | Purchase | 4,000 | $1.49 | Discretionary |
Kentaro Suzuki currently holds 4,000 shares of Nautilus Biotechnology, Inc. (NAUT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kentaro Suzuki has been a net buyer of NAUT stock. They have purchased $6.0K and sold $0 worth of shares.
Kentaro Suzuki's most recent insider trade was on Nov 6, 2025, when they purchased 4,000 shares at $1.49 per share.
Get notified when new Form 4 filings are submitted